These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25563991)

  • 1. New insights into T-cell cosignaling in allograft rejection and survival.
    Krummey SM; Ford ML
    Curr Opin Organ Transplant; 2015 Feb; 20(1):43-8. PubMed ID: 25563991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
    Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
    Nature; 1996 May; 381(6581):434-8. PubMed ID: 8632801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
    Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
    Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the immunotherapeutic potential of T-lymphocyte co-signaling molecules in transplantation.
    Ansari AW; Khan MA; Schmidt RE; Broering DC
    Immunol Lett; 2017 Mar; 183():8-16. PubMed ID: 28119073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of costimulatory pathways of T-cell activation: the solution to acute and chronic rejection?
    van Kooten C
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):675-80. PubMed ID: 10630812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D; Li J; Orosz CG; Bumgardner GL
    Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T Cell Cosignaling Molecules in Transplantation.
    Ford ML
    Immunity; 2016 May; 44(5):1020-33. PubMed ID: 27192567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3+ regulatory T cells are activated in spite of B7-CD28 and CD40-CD40L blockade.
    Vogel I; Verbinnen B; Maes W; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2013 Apr; 43(4):1013-23. PubMed ID: 23348953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.
    Gajardo T; Morales RA; Campos-Mora M; Campos-Acuña J; Pino-Lagos K
    Immunology; 2015 Sep; 146(1):81-8. PubMed ID: 25988395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Costimulatory Pathways in Transplant Tolerance.
    Uehara M; McGrath MM
    Clin Lab Med; 2019 Mar; 39(1):87-106. PubMed ID: 30709511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.
    Wood S; Feng J; Chung J; Radojcic V; Sandy-Sloat AR; Friedman A; Shelton A; Yan M; Siebel CW; Bishop DK; Maillard I
    J Immunol; 2015 Mar; 194(6):2899-908. PubMed ID: 25687759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.
    Denton MD; Reul RM; Dharnidharka VR; Fang JC; Ganz P; Briscoe DM
    Pediatr Transplant; 1998 Feb; 2(1):6-15. PubMed ID: 10084754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
    J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
    Gaweco AS; Mitchell BL; Lucas BA; McClatchey KD; Van Thiel DH
    Kidney Int; 1999 Apr; 55(4):1543-52. PubMed ID: 10201021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
    Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of positive costimulatory molecules in transplantation and tolerance.
    Agarwal A; Newell KA
    Curr Opin Organ Transplant; 2008 Aug; 13(4):366-72. PubMed ID: 18685331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.